Archives
-
PP2A Links Autophagy to Candida Biofilm Drug Resistance
2026-09-26
The study links the PP2A catalytic subunit gene PPH21 to autophagy, biofilm formation, and antifungal resistance in Candida albicans. Its mutant and rapamycin experiments support a model in which PP2A-associated Atg13 phosphorylation helps activate Atg1, while the oral-infection mouse findings suggest that autophagy can reduce antifungal treatment efficacy in this setting.
-
(S)-Mephenytoin in Organoid PK Workflows
2026-09-25
Pair a defined CYP2C19 probe with human iPSC-derived intestinal models to ask whether a system supports measurable oxidative metabolism—not simply whether cells survive compound exposure. This practical guide separates established product and organoid findings from proposed assay conditions, with qualification steps for interpreting results.
-
PP2A Links Autophagy to Candida Biofilm Drug Resistance
2026-09-25
The study links the PP2A catalytic-subunit gene PPH21 to autophagy, biofilm formation, and antifungal response in Candida albicans. Its genetic, pharmacological, and mouse-model findings point to Atg13-associated regulation and Atg1 as candidate parts of this relationship, while leaving important questions about drug-specific effects and clinical transferability.
-
Açaí Extracts: Hepatocyte Toxicity and Induction
2026-09-24
This study compared açaí extracts from berry powder and commercial supplements using human hepatocytes and a complementary transporter assay. Some extracts reduced hepatocyte viability in a dose- and time-dependent manner, but the study found no significant induction of the tested CYP enzymes or transporters, emphasizing the need to separate cytotoxicity from interaction potential.
-
HPF (Hydroxyphenyl Fluorescein): Specificity and Use
2026-09-24
HPF (hydroxyphenyl fluorescein) is an oxidation-activated fluorescent probe for detecting highly reactive oxygen species, including hydroxyl radicals and peroxynitrite. Its selectivity profile makes it useful for intracellular oxidative stress visualization, but its fluorescence is not a direct measure of total ROS or a substitute for independent mechanistic validation.
-
Danazol Workflows for Endocrine Model Research
2026-09-23
Use Danazol to probe steroidogenesis and hypothalamic–pituitary–gonadal signaling, with a practical workflow that connects cell-based assays to developmental models. A recent rat study highlights how Danazol-induced puberty models can test interventions while underscoring the need to separate measured endpoints from inferred mechanisms.
-
Sulfaphenazole: CYP2C9 Inhibitor Workflows
2026-09-23
Sulfaphenazole supports two complementary research paths: controlled CYP2C9 inhibition for drug metabolism and vascular assays, plus in vitro antibacterial testing. This guide translates published vascular findings into executable workflows, controls, troubleshooting decisions, and cross-domain study designs.
-
Tetracycline Workflows for Reliable Ribosome Research
2026-09-22
Tetracycline combines reversible ribosomal targeting with practical value as an antibiotic selection marker and microbiological research tool. This workflow-focused guide shows how to build reproducible bacterial assays while responsibly separating those applications from LKB1–telomerase findings in lung adenocarcinoma.
-
Pravastatin Sodium in Transporter-Aware Assays
2026-09-22
Pravastatin sodium is a selective HMG-CoA reductase inhibitor whose assay behavior depends on both target engagement and cellular transport. This guide connects cholesterol biosynthesis inhibition with hepatocyte viability, OATP biology, and botanical-drug interaction screening for more interpretable translational experiments.
-
β-NMN: NAD+ Precursor for Metabolic Research
2026-09-21
beta-Nicotinamide mononucleotide (β-NMN) is a nicotinamide adenine dinucleotide precursor for controlled studies of NAD+ biosynthesis, glucose-stimulated insulin secretion, and metabolic regulation. Preclinical evidence supports its use in obesity, diabetes, and diabetic cardiac-fibrosis models, but it does not establish a human treatment benefit.
-
HyperScript First-Strand cDNA Synthesis Kit Workflow
2026-09-21
The HyperScript First-Strand cDNA Synthesis Kit supports sensitive transcript analysis when RNA is scarce, structured, or derived from mixed host–microbe samples. Its temperature-tolerant reverse transcriptase and flexible primer selection help connect RNA template reverse transcription with reliable PCR amplification and qPCR reaction design.
-
4-Hydroxytamoxifen: DMSO Workflow Guide
2026-09-20
4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled cell, cardiac myocyte, and selected mouse-model workflows. It should not be selected for protocols that require water- or ethanol-based preparation, and solution storage should be minimized to protect reproducibility.
-
L-Phenylephrine: A Sex-Aware α1A Assay Framework
2026-09-19
L-Phenylephrine is an adrenergic α1A receptor agonist that can connect receptor-selective cell assays with sex-dependent cardiovascular physiology. This article shows how to interpret α1-adrenergic receptor signaling, baroreflex responses, and cardiomyocyte endpoints without confusing direct agonism with systemic sympathetic effects.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-18
Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be cryopreserved, expanded, and differentiated into epithelial cells with intestinal transporter and cytochrome P450 activities, supporting more human-relevant pharmacokinetic studies.
-
In Vitro Drug Response Metrics in Cancer
2026-09-18
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent components of an in vitro drug response. The framework supports more precise assay design, time-course interpretation, and reporting of anticancer drug effects.